MiR‐9 downregulates CDX2 expression in gastric cancer cells
- 25 March 2011
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 129 (11), 2611-2620
- https://doi.org/10.1002/ijc.25923
Abstract
Ectopic expression of CDX2, a caudal‐related homeobox protein, is known to be associated with the development of intestinal metaplasia in the stomach and gastric carcinogenesis. Previously, we reported that DNA methylation was partly responsible for CDX2 silencing in gastric cancer (GC). However, the mechanism underlying the aberrant expression of CDX2 during malignant transformation remained unclear. MicroRNAs (miRNAs) are small non‐coding RNAs that function as post‐transcriptional regulators. To elucidate the role of miRNAs in CDX2 downregulation in GC cells, putative miRNAs, such as miR‐9, were computationally predicted. After exogenous pre‐miR‐9 precursor transfection, the luciferase activity of a reporter vector containing a part of the 3′‐UTR of CDX2 was downregulated in HEK‐293T cells. The inverse correlation between the miR‐9 and CDX2 protein levels was demonstrated in GC cell lines. By means of miR‐9 overexpression and knockdown techniques, the expression levels of the CDX2 protein and downstream target genes (p21, MUC2 and TFF3) were responsively altered in MKN45 and NUGC‐3 cells. Transfection of an anti‐miR‐9 molecule significantly inhibited cell growth by promoting G1 cell cycle arrest in MKN45 cells similarly to the effect of CDX2 overexpression. Moreover, examination of the miR‐9 levels in primary GC tissues revealed that the amounts of miR‐9 in the CDX2‐negative group were significantly higher than those in the CDX2‐positive group (p = 0.004). Therefore, miR‐9 might repress CDX2 expression via the binding site in the 3′‐UTR, resulting in the promotion of cell proliferation in GCs.Keywords
This publication has 40 references indexed in Scilit:
- CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significanceLaboratory Investigation, 2010
- Intestinal metaplasia: A premalignant lesion involved in gastric carcinogenesisJournal of Gastroenterology and Hepatology, 2009
- CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancerLaboratory Investigation, 2007
- Development of Gastric Carcinoma from Intestinal Metaplasia in Cdx2-transgenic MiceCancer Research, 2004
- Control of gut differentiation and intestinal-type gastric carcinogenesisNature Reviews Cancer, 2003
- Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic miceGastroenterology, 2002
- Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomachCancer Letters, 2002
- Cdx1 and Cdx2 expression during intestinal developmentGastroenterology, 2000
- E-Cadherin Gene Promoter Hypermethylation in Primary Human Gastric CarcinomasJNCI Journal of the National Cancer Institute, 2000
- THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO‐CALLED INTESTINAL‐TYPE CARCINOMAActa Pathologica Microbiologica Scandinavica, 1965